Group 1 - First Busey reported quarterly earnings of $0.63 per share, exceeding the Zacks Consensus Estimate of $0.61 per share, and up from $0.50 per share a year ago, representing an earnings surprise of +3.28% [1] - The company posted revenues of $198.05 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.10%, compared to year-ago revenues of $116.24 million [2] - First Busey has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times during the same period [2] Group 2 - The stock's immediate price movement will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - First Busey shares have increased by approximately 2.4% since the beginning of the year, while the S&P 500 has gained 7.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.62 on revenues of $195.9 million, and for the current fiscal year, it is $2.49 on revenues of $728.85 million [7] Group 3 - The Zacks Industry Rank for Banks - Midwest is currently in the top 31% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for First Busey was unfavorable ahead of the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6]

Company Overview - Beyond (BYON) shares increased by 22.5% to $10.84 in the last trading session, with a notable trading volume, and have gained 47% over the past four weeks [1] - The company is benefiting from the resurgence of the Overstock.com brand, a reimagined Bed Bath & Beyond with significant SKU reduction, and the acquisition of buybuy BABY [2] Financial Performance - Beyond is expected to report a quarterly loss of $0.37 per share, reflecting a year-over-year change of +51.3%, with revenues projected at $261.38 million, down 34.3% from the previous year [3] - The consensus EPS estimate for Beyond has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] Industry Context - Beyond operates within the Zacks Internet - Commerce industry, where eBay (EBAY) also operates, finishing the last trading session 1.1% higher at $79.03, with a 0.7% return over the past month [4] - eBay's consensus EPS estimate for its upcoming report is $1.3, representing a +10.2% change from the previous year, and it currently holds a Zacks Rank of 2 (Buy) [5]

Core Viewpoint - atai Life Sciences N.V. (ATAI) has been upgraded to a Zacks Rank 1 (Strong Buy) due to an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the importance of changing earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - Rising earnings estimates for atai Life Sciences indicate an improvement in the company's underlying business, likely leading to an increase in stock price [5][10]. Zacks Rating System - The Zacks Rank stock-rating system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7][9]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [9][10]. Recent Earnings Estimate Revisions - For the fiscal year ending December 2025, atai Life Sciences is expected to earn -$0.54 per share, unchanged from the previous year [8]. - Over the past three months, the Zacks Consensus Estimate for atai Life Sciences has increased by 27.9% [8].

分组1 - PepsiCo reported quarterly earnings of $2.12 per share, exceeding the Zacks Consensus Estimate of $2.03 per share, but down from $2.28 per share a year ago, representing an earnings surprise of +4.43% [1] - The company posted revenues of $22.73 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.51% and showing an increase from $22.5 billion year-over-year [2] - Over the last four quarters, PepsiCo has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 11% since the beginning of the year compared to the S&P 500's gain of 6.5% [3] - The current consensus EPS estimate for the coming quarter is $2.35 on revenues of $23.63 billion, and for the current fiscal year, it is $7.87 on revenues of $92.47 billion [7] - The Zacks Industry Rank for Beverages - Soft drinks is currently in the top 33% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] 分组3 - Ahead of the earnings release, the estimate revisions trend for PepsiCo was mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - Another company in the same industry, Vita Coco Company, Inc., is expected to report quarterly earnings of $0.37 per share, reflecting a year-over-year change of +15.6% [9]

Core Viewpoint - Hilton Worldwide Holdings Inc. (HLT) shares experienced a 3.1% increase, reflecting strong demand in the hospitality sector and positive investor sentiment driven by earnings growth expectations [1][2]. Company Performance - HLT shares closed at $265.5, with a notable trading volume that exceeded the average [1]. - The stock has gained 3.7% over the past four weeks, indicating a positive trend [1]. Revenue and Earnings Expectations - The company is projected to report quarterly earnings of $2.01 per share, representing a year-over-year increase of 5.2% [3]. - Expected revenues for the upcoming quarter are $3.07 billion, which is a 3.9% increase compared to the same quarter last year [3]. Analyst Sentiment - Analysts have slightly revised the consensus EPS estimate higher over the last 30 days, which typically correlates with stock price appreciation [4]. - Positive trends in earnings estimate revisions are expected to support further price strength for HLT [4]. Industry Context - Hilton Worldwide is part of the Zacks Hotels and Motels industry, which is currently experiencing strong demand across leisure, business, and group travel segments [2]. - Another company in the same industry, Choice Hotels (CHH), also showed a positive performance, closing 0.7% higher [5].

Company Overview - Outset Medical, Inc. (OM) shares increased by 15% to close at $19.97, with trading volume significantly higher than usual, contrasting with a 3.2% loss over the past four weeks [1][2] Financial Performance - The company reported strong financial results for Q1 2025, driven by optimism regarding its expanding installed base and recurring revenue potential from the Tablo dialysis system [2] - Outset Medical is expected to report a quarterly loss of $1.76 per share, reflecting a year-over-year change of +75%, with revenues projected at $29.77 million, an increase of 8.7% from the previous year [3] Earnings Estimates and Stock Movement - The consensus EPS estimate for Outset Medical has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [4] - The stock currently holds a Zacks Rank of 3 (Hold), suggesting a neutral outlook [4] Industry Context - Outset Medical is part of the Zacks Medical Info Systems industry, which includes other companies like Senseonics Holdings (SENS), which saw a 1.2% increase in its last trading session [4] - Senseonics has a consensus EPS estimate of -$0.02, representing a year-over-year change of +33.3%, and currently holds a Zacks Rank of 2 (Buy) [5]

Group 1 - United States Steel (X) shares increased by 5.1% to close at $54.85, with a notable volume of shares traded, reflecting a 29.3% gain over the past four weeks [1][2] - The rally in U.S. Steel's shares followed President Trump's approval of its partnership with Nippon Steel, which included a National Security Agreement (NSA) involving approximately $11 billion in new investments by 2028 [2] - U.S. Steel is projected to report quarterly earnings of $0.41 per share, indicating a year-over-year decline of 51.2%, with expected revenues of $4.07 billion, down 1.1% from the previous year [3] Group 2 - The consensus EPS estimate for U.S. Steel has been revised 1.1% higher in the last 30 days, suggesting a potential for price appreciation [4] - U.S. Steel holds a Zacks Rank of 3 (Hold), indicating a neutral outlook within the Zacks Steel - Producers industry [5] - ArcelorMittal, another company in the same industry, closed 2.9% higher at $30.99, with a consensus EPS estimate of $1.11, reflecting a year-over-year increase of 76.2% [5][6]

Company Performance - Ibotta reported quarterly earnings of $0.02 per share, exceeding the Zacks Consensus Estimate of $0.01 per share, compared to earnings of $0.54 per share a year ago, representing an earnings surprise of 100% [1] - The company posted revenues of $84.57 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.52%, and showing an increase from year-ago revenues of $82.33 million [2] - Over the last four quarters, Ibotta has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Outlook - Ibotta shares have declined approximately 23.2% since the beginning of the year, while the S&P 500 has gained 0.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $89.9 million, and for the current fiscal year, it is $1.20 on revenues of $384.6 million [7] - The estimate revisions trend for Ibotta is mixed, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market in the near future [6] Industry Context - The Technology Services industry, to which Ibotta belongs, is currently ranked in the top 22% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Company Overview - Hims & Hers Health, Inc. (HIMS) shares increased by 23% to close at $35.04, with trading volume significantly higher than usual, contrasting with a 3.6% loss over the previous four weeks [1][2] Recent Developments - The surge in Hims & Hers Health's shares is linked to the announcement of a deal to sell Novo Nordisk's weight-loss drug, Wegovy, on its telehealth platform, allowing U.S. customers to access NovoCare Pharmacy through Hims & Hers for $599 per month [2] Financial Performance Expectations - The company is projected to report quarterly earnings of $0.14 per share, reflecting a year-over-year increase of 180%, with revenues expected to reach $537.85 million, a 93.4% rise from the same quarter last year [3] - The consensus EPS estimate for the upcoming quarter has been revised 21.3% higher in the last 30 days, indicating a positive trend that typically correlates with stock price appreciation [4] Industry Context - Hims & Hers Health is categorized within the Zacks Medical Info Systems industry, where Health Catalyst (HCAT) is another player, having closed 0.3% higher at $4.07 but showing a -10.4% return over the past month [4]

M/I Homes (MHO) came out with quarterly earnings of $3.98 per share, missing the Zacks Consensus Estimate of $4.16 per share. This compares to earnings of $4.78 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of -4.33%. A quarter ago, it was expected that this homebuilder would post earnings of $4.83 per share when it actually produced earnings of $4.71, delivering a surprise of -2.48%. Over the last four quarters, the company ...